{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:20:47Z","timestamp":1792603247604,"version":"4.5.0"},"reference-count":19,"publisher":"Scientific Scholar","content-domain":{"domain":["clinicalimagingscience.org"],"crossmark-restriction":true},"short-container-title":["JCIS"],"abstract":"\nObjectives:<\/jats:title>\nThe objectives of this study are to assess the utility of whole-body 18<\/jats:sup>F-fluorodeoxyglucose positron emission tomography\/computed tomography (18<\/jats:sup>F-FDG PET\/CT) (skull vertex to toes) imaging relative to the standard field of view (skull base to mid-thigh) in patients with primary melanoma site that is not located in the lower extremities.<\/jats:p>\n<\/jats:sec>\n\nMaterial and Methods:<\/jats:title>\nThe primary site of the melanoma and metastatic disease was determined based on 18<\/jats:sup>F-FDG PET\/CT findings in 26 patients. The FDG avid sites were tabulated as the primary site, lower extremity, brain, and other sites. The hypothesis is that routine skull base to mid-thigh versus whole-body 18<\/jats:sup>F-FDG PET\/CT in patients with malignant melanoma will not change management.<\/jats:p>\n<\/jats:sec>\n\nResults:<\/jats:title>\nPatients (26) were divided into those with primary melanoma site in either the lower extremities (six patients) or other site (20 patients). Four of the six patients with the primary site in the lower extremities also had positive findings in the ipsilateral inguinal lymph nodes. One of the patients with a positive inguinal lymph node had metastatic sites in the external iliac region and lungs on the initial study. On follow-up imaging, this patient also exhibited diffuse metastatic disease, including a lower extremity. None of the remaining patients in this group had positive findings other than the primary site in the lower extremity. Of the remaining 20 patients with the primary site not in the lower extremity, one had diffuse metastatic disease that included a lower extremity. However, lower extremity involvement would not change patient management in this case. A second patient in this group had diffuse metastatic disease that also involved the brain. However, no metastatic disease was present in the lower extremities in this patient. None of the remaining 18 patients in this group had metastatic disease in a lower extremity. Two patients in the entire study group of 26 had brain metastasis on contrast-enhanced head CT, with one having multiple brain metastasis. PET failed to demonstrate some of the brain lesions. In the other patient with solitary brain metastasis detected on contrast-enhanced head CT, PET was negative.<\/jats:p>\n<\/jats:sec>\n\nConclusion:<\/jats:title>\n18<\/jats:sup>F-FDG PET\/CT imaging of the lower extremity may not be justified if the primary neoplasm is not located in the lower extremities. Elimination of lower extremity imaging will reduce scanning time and additional radiation exposure. Similarly, PET\/CT imaging of the brain may not be justified if contrast-enhanced CT or magnetic resonance imaging of the head is already obtained since these are more sensitive.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/jcis_93_2020","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T04:09:06Z","timestamp":1596254946000},"page":"47","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Whole-Body versus Routine Skull Base to Mid-thigh 18<\/sup>F-Fluorodeoxyglucose Positron Emission Tomography\/ Computed Tomography in Patients with Malignant Melanoma"],"prefix":"10.25259","volume":"10","author":[{"given":"Savas","family":"Ozdemir","sequence":"first","affiliation":[{"name":"Department of Radiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, United States,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"McCook","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, United States,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Klassen","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, United States,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"key":"10.25259\/JCIS_93_2020\/ref-1","author":"Cancer Stat Facts: Melanoma of the Skin","year":"2020","unstructured":"Available from: https:\/\/www.seer.cancer.gov\/statfacts\/html\/melan.html [Last accessed on 2020 May 30]"},{"key":"10.25259\/JCIS_93_2020\/ref-2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s00259-009-1224-8","article-title":"Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma","volume":"37","author":"Jim\u00e9nez-Requena","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.25259\/JCIS_93_2020\/ref-3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/RLU.0000000000000996","article-title":"18F-FDG-PET\/CT in the staging and management of melanoma: A prospective multicenter Ontario PET registry study","volume":"41","author":"Singnurkar","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.25259\/JCIS_93_2020\/ref-4","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/1097-0142(20010415)91:8<1530::AID-CNCR1162>3.0.CO;2-#","article-title":"Systematic review of the diagnostic accuracy of 18f-fluorodeoxyglucose positron emission tomography in melanoma patients","volume":"91","author":"Mijnhout","year":"2001","journal-title":"Cancer"},{"key":"10.25259\/JCIS_93_2020\/ref-5","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1200\/JCO.2005.03.5634","article-title":"Diagnostic performance of whole body dual modality 18F-FDG PET\/CT imaging for N-and M-staging of malignant melanoma experience with 250 consecutive patients","volume":"24","author":"Reinhardt","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.25259\/JCIS_93_2020\/ref-6","first-page":"17","article-title":"Positron emission tomography in the follow-up of cutaneous malignant melanoma patients: A systematic review","volume":"4","author":"Danielsen","year":"2014","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.25259\/JCIS_93_2020\/ref-7","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1245\/s10434-013-2969-7","article-title":"Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup","volume":"20","author":"Niebling","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.25259\/JCIS_93_2020\/ref-8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1148\/radiol.2382041977","article-title":"Integrated PET CT: Current applications and future directions","volume":"238","author":"Von Schulthess","year":"2006","journal-title":"Radiology"},{"key":"10.25259\/JCIS_93_2020\/ref-9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/jso.21816","article-title":"Cutaneous melanoma: A model to study cancer metastasis","volume":"103","author":"Leong","year":"2011","journal-title":"J Surg Oncol"},{"key":"10.25259\/JCIS_93_2020\/ref-10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1148\/radiology.195.3.7753998","article-title":"Malignant melanoma: Staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose","volume":"195","author":"Steinert","year":"1995","journal-title":"Radiology"},{"key":"10.25259\/JCIS_93_2020\/ref-11","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2214\/AJR.09.3731","article-title":"18F-FDG PET\/CT of patients with cancer: Comparison of whole-body and limited whole-body technique","volume":"195","author":"Osman","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.25259\/JCIS_93_2020\/ref-12","doi-asserted-by":"publisher","first-page":"902","DOI":"10.2214\/AJR.11.7280","article-title":"PET\/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: Evaluation of the additive value after conventional imaging","volume":"198","author":"Bronstein","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.25259\/JCIS_93_2020\/ref-13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1148\/radiol.2261010920","article-title":"Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of noncentral nervous system malignancy","volume":"226","author":"Rohren","year":"2003","journal-title":"Radiology"},{"key":"10.25259\/JCIS_93_2020\/ref-14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/MNM.0b013e32827420cc","article-title":"Clinical value of including the head and lower extremities in 18F-FDG PET\/ CT imaging for patients with malignant melanoma","volume":"28","author":"Niederkohr","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.25259\/JCIS_93_2020\/ref-15","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/MNM.0b013e32833cb8b7","article-title":"Clinical and therapeutic impact of 18F-FDG PET\/CT whole-body acquisition including lower limbs in patients with malignant melanoma","volume":"31","author":"Querellou","year":"2010","journal-title":"Nucl Med Commun"},{"key":"10.25259\/JCIS_93_2020\/ref-16","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1097\/RLU.0b013e3182a77cae","article-title":"Comparison of whole-body versus limited whole-body 18F-FDG PET\/CT scan in malignant cutaneous melanoma","volume":"38","author":"Lazaga","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.25259\/JCIS_93_2020\/ref-17","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1097\/MNM.0000000000000747","article-title":"Clinical relevance of 18F-FDG PET\/CT lower-limb imaging in patients with malignant cutaneous melanoma","volume":"38","author":"Plouznikoff","year":"2017","journal-title":"Nucl Med Commun"},{"key":"10.25259\/JCIS_93_2020\/ref-18","first-page":"202","article-title":"Is there an added clinical value of \u201cTrue\u201d whole body (18)F-FDG PET\/CT imaging in patients with malignant melanoma","volume":"15","author":"Tan","year":"2012","journal-title":"Hell J Nucl Med"},{"key":"10.25259\/JCIS_93_2020\/ref-19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cpet.2017.05.002","article-title":"Precision medicine and PET\/computed tomography in melanoma","volume":"12","author":"Mena","year":"2017","journal-title":"PET Clin"}],"container-title":["Journal of Clinical Imaging Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/clinicalimagingscience.org\/whole-body-versus-routine-skull-base-to-mid-thigh-f-fluorodeoxyglucose-positron-emission-tomography-computed-tomography-in-patients-with-malignant-melanoma\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/clinicalimagingscience.org\/whole-body-versus-routine-skull-base-to-mid-thigh-f-fluorodeoxyglucose-positron-emission-tomography-computed-tomography-in-patients-with-malignant-melanoma\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T12:17:24Z","timestamp":1679314644000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalimagingscience.org\/whole-body-versus-routine-skull-base-to-mid-thigh-f-fluorodeoxyglucose-positron-emission-tomography-computed-tomography-in-patients-with-malignant-melanoma\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":19,"alternative-id":["10.25259\/JCIS_93_2020"],"URL":"https:\/\/doi.org\/10.25259\/jcis_93_2020","relation":{},"ISSN":["2156-5597","2156-7514"],"issn-type":[{"value":"2156-5597","type":"electronic"},{"value":"2156-7514","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,1]]},"article-number":"47"}}